Clinical Trials Logo

Muscle Cramp clinical trials

View clinical trials related to Muscle Cramp.

Filter by:

NCT ID: NCT02092883 Completed - Infantile Spasms Clinical Trials

Evaluation of Neuroinflammation in Children With Infantile Spasms

Start date: March 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study was to investigate the presence of neuroinflammation in children with infantile spasms using 11C-PK11195 positron emission tomography (PK PET) scan, and its response to ACTH treatment by repeating the PK PET scan after treatment.

NCT ID: NCT02032758 Completed - Clinical trials for Occupational; Cramp(s)

Study of Arm and Putter Movement in Golfers With Golfer's Cramp

Start date: January 2014
Phase: Phase 4
Study type: Interventional

The investigators will investigate golfers with visual evidence of an involuntary movement while putting before and after treatment with a low dose of propranolol.

NCT ID: NCT01882790 Completed - Hypertension Clinical Trials

The Prevalence of Coronary Spasm in Hypertensive Patients Treated With Antihypertensive Medication

Start date: May 2013
Phase: N/A
Study type: Observational [Patient Registry]

Autonomic nerve function is involved in both blood pressure (BP) regulation and the pathogenesis of coronary artery spasm(CAS), but few studies have been published about the relationship between CAS and effect of BP lowering drugs in patients with hypertension. The purpose of this study is to investigate the incidence of CAS, atrioventricular (AV) block and effect of BP lowering drugs on CAS in hypertensive patients treated with BP lowering agents. The investigators will register consecutive patients who underwent coronary angiography with an acetylcholine (Ach)-induced provocation test. The investigators will include hypertensive patients who were taking antihypertensive drugs, and exclude patients who had a documented history of cardiovascular disease or who were not treated with antihypertensive agents. CAS is defined as >70% luminal narrowing on Ach provocation and /or concurrent chest pain. The study population will be divided into quartiles of rising systolic BP and diastolic BP. The incidence of Ach-induced CAS according to each systolic BP/diastolic BP quartile will be evaluated.

NCT ID: NCT01811355 Active, not recruiting - Clinical trials for Muscle Cramps in Amyotrophic Lateral Sclerosis

Mexiletine for the Treatment of Muscle Cramps in ALS

Start date: May 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if mexiletine is effective for the treatment of muscle cramps in Amyotrophic Lateral Sclerosis (ALS).

NCT ID: NCT01726725 Unknown status - Hemifacial Spasm Clinical Trials

Hemifacial Spasm and Desflurane

HFS
Start date: November 2012
Phase: N/A
Study type: Observational

Patients are chosen to participate in this study because they will undergo a particular type of brain surgery to treat their hemifacial spasm. This surgery is called microvascular decompression (MVD) and involves the facial nerve. The facial nerve is being compressed by one or more blood vessels and this contact produces the facial twitches. The investigators do not know why a blood vessel that touches the facial nerve produces facial twitches. The investigators are interested in investigating this during your surgery. A total of 25 participants are expected to participate in this study.

NCT ID: NCT01709968 Terminated - Quality of Life Clinical Trials

Magnesium Oxide Monohydrate for Nocturnal Leg Cramps

MgNLC
Start date: February 2013
Phase: Phase 4
Study type: Interventional

Nocturnal leg cramps (NLC) are painful, involuntary contractions of muscles occurring at rest, mostly at night. A Cochrane review on leg cramps in pregnancy showed some potential benefits in trials of magnesium. This is a single center, prospective, randomized, double blind, placebo controlled clinical trial that aims to investigate the effect of treatment with Magnox 520® (un-organic granular magnesium complex, composed of Magnesium Oxide & Magnesium Oxide Monohydrate 865mg, Provides 520 mg of free elemental Mg++) on frequency and severity of NLC, quality of sleep and quality of life. Hypothesis: Magnox 520® may reduce the number and severity of NLC; an improvement in the quality of life and quality of sleep may ensue.

NCT ID: NCT01564979 Unknown status - Hemifacial Spasm Clinical Trials

Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm

Start date: April 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether pretarsal and preseptal techniques of Botulinum toxin type A injection have any effect on tear functions.

NCT ID: NCT01553201 Completed - Quality of Life Clinical Trials

Botulinum Toxin for Pelvic Pain in Women With Endometriosis

Start date: July 30, 2014
Phase: Phase 1/Phase 2
Study type: Interventional

Background: - Some women with endometriosis have chronic pelvic pain. This pain may be caused by spasms of the pelvic floor muscles. These spasms can be detected by an examination. Studies suggest that botulinum toxin can help treat problems caused by muscle spasms. Researchers want to see if botulinum toxin injections into the pelvic floor muscles can decrease pain and spasms in women with pelvic pain. Objectives: - To see if botulinum toxin can relieve pain from pelvic floor spasm in women with pelvic pain. Eligibility: - Women between 18 and 50 years of age with pain associated with pelvic muscle spasm and endometriosis. Pain must be persistent (lasting for at least 3 months). Design: - Participants will keep a pain diary and record their pain medication use for a month before the first visit. - Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. Participants will also answer questions about their pain levels and quality of life. - Participants will receive either botulinum toxin or a placebo (salt water) injection. The injection will be given into the pelvic floor muscles through the vaginal wall. Participants will take a muscle relaxant like Valium and have anesthetic cream put on the vaginal wall before the injection. - After the injection, participants will keep a pain diary for another month. - At a 1-month followup visit, participants will answer questions about their pain. If the pain has not improved, all participants may have a botulinum toxin injection (no placebo) into the pelvic floor muscles as before. - Participants will have followup visits for up to a year after the initial 1-month followup visit.

NCT ID: NCT01546805 Not yet recruiting - Blepharospasm Clinical Trials

Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm

Start date: April 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether zinc supplements are effective in enhancing the treatment of oculofacial spasm disorders with botulinum toxin.

NCT ID: NCT01495403 Completed - Liver Cirrhosis Clinical Trials

Treatment of Muscle Cramps in Patients With Liver Cirrhosis

Start date: December 2011
Phase: Early Phase 1
Study type: Interventional

This is a pilot study to see if hydroxychloroquine (HCQ) if safe and effective to use with patients having cramps due to their cirrhotic liver disease.